Une feuille de route pour l'équité en matière de cannabis au Canada afin d'éclairer l'examen législatif de la loi sur le cannabis

Centre on Drug Policy Evaluation

Publications

Une feuille de route pour l'équité en matière de cannabis au Canada afin d'éclairer l'examen législatif de la loi sur le cannabis

12 novembre 2023

Le Centre d'évaluation des politiques en matière de drogues décrit comment la responsabilité sociale et l'équité peuvent être renforcées dans la législation canadienne sur le cannabis, en mettant l'accent sur l'inclusion des personnes racialisées et des genres sous-représentés, la réparation des préjudices causés par la prohibition du cannabis grâce au réinvestissement des taxes et l'amnistie pour les condamnations antérieures liées au cannabis. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Toronto, Canada – A report released today (16th October 2023) by the Centre on Drug Policy Evaluation (CDPE) offers recommendations for advancing equitable cannabis policies in Canada.

Released to respond to the ongoing legislative review of the Cannabis Act, this new report provides a guide for improving equity and social justice after five years of Canada’s legalization and regulation of non-medical cannabis markets. A top line recommendation is that the purpose of the Cannabis Act be expanded to include the promotion of social responsibility and social equity in connection with cannabis.

“Canada has a transformational opportunity with the legislative review of the Cannabis Act to build cannabis policies that prioritize racial and social justice,” said Dr. Akwasi Owusu-Bempah, Associate Professor in the Department of Sociology at the University of Toronto and senior author of the report. “An essential first step is formally adding equity as a key goal of Canada’s cannabis policy alongside public health and safety objectives.”

Black and Indigenous people, who have been disproportionately negatively impacted by cannabis prohibition in Canada, as well as women, are notably absent from leadership positions within the Canadian cannabis industry. In comparison to many jurisdictions in the United States, Canadian legalization efforts have done little to explicitly address the harms caused by drug prohibition and to foster equity in the legal cannabis industry.